Retrovirus Vector Gene Transfer Adipocytes

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for gene transfer into adipocytes or preadipocytes are inefficient, lacking a functional substance that enhances retrovirus infectivity, which is crucial for effective gene therapy applications.

Innovation Solution

The use of a substance with both retrovirus-binding and target cell-binding sites, specifically containing regions capable of binding to VLA-5 and/or VLA-4, such as the heparin-II domain of fibronectin, fibroblast growth factor, or polylysine, to colocalize the retrovirus vector with adipocytes or preadipocytes, increasing the efficiency of gene transfer.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a retrovirus vector is used for gene transfer into adipocytes or preadipocytes without a functional substance, then the procedure is simple, but the infectivity and gene transfer efficiency are low

Engineering Contradiction:
Improvegene transfer efficiencyVSAvoidcomplexity of infection system
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The patent introduces a functional substance as an intermediary mediator between the retrovirus vector and adipocytes/preadipocytes. This substance binds to both the retrovirus and the target cell, facilitating efficient colocalization and gene transfer. The functional substance acts as a bridge that resolves the low efficiency problem without requiring complex modification of the virus or cell systems.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If no functional substance is used to bind retrovirus to adipocytes, then the system remains simple, but the infectivity is insufficient for effective gene therapy

Engineering Contradiction:
Improveretrovirus infectivityVSAvoidcomplexity of binding system
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The functional substance is designed with multi-functionality: it simultaneously binds to the retrovirus vector and to adipocytes/preadipocytes through specific binding sites. This universal binder performs multiple functions (virus attachment, cell attachment, colocalization facilitation) with a single component, thereby improving infectivity without proportionally increasing system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables high-efficiency gene transfer into adipocytes or preadipocytes, facilitating their use in gene therapy by producing transformed cells that can treat or prevent diseases.

Implementation Method 1

a substance having a retrovirus-binding site and a target cell-binding site in a single molecule, or a mixture of a substance having a retrovirus-binding site and another substance having a target cell-binding site, wherein the target cell-binding site contains a region capable of binding to VLA-5 and/or a region capable of binding to VLA-4

Methodology Applied
Scientific EffectBinding:

Data Source

PatentUS8835177B2Method for transfer of gene into fat cell or progenitor fat cell
Publication Date: 2014.09.16 TAKARA BIO INC

AI summary

A method for transferring a gene into a fat cell or progenitor fat cell comprising the step of infecting the fat cell or progenitor cell with a retrovirus vector having a foreign gene in the presence of a substance having both of a retrovirus-binding site and a target cell-binding site in the molecule or a mixture of a substance having a retrovirus-binding site and a substance having a target cell-binding site, the target cell-binding site having a region that can bind to VLA-5 and/or a region that can bind to VLA-4.